Schrodinger. has filed a patent for compounds of Formula (I) that act as MALT1 inhibitors. These compounds, along with their pharmaceutically acceptable salts, are intended for treating diseases like cancer, autoimmune disorders, and inflammatory disorders. GlobalData’s report on Schrodinger gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Schrodinger, AI-assisted drug repurposing was a key innovation area identified from patents. Schrodinger's grant share as of January 2024 was 48%. Grant share is based on the ratio of number of grants to total number of patents.
A patent application (Publication Number: US20240018157A1) has been filed for a compound of Formula (I) or a pharmaceutically acceptable salt thereof. The compound can have various configurations based on the values of X, Y, Z, R1, R2, R3, R4, R5, and R6 as specified in the claims. The patent covers a wide range of possible compounds with different substituents and configurations, allowing for potential applications in the treatment of various diseases and disorders. The claims also include methods for preparing the compound, pharmaceutical compositions containing the compound, and methods for treating conditions such as cancer, autoimmune disorders, and inflammatory disorders by administering the compound.
The patent application outlines specific configurations and substitutions for the compound of Formula (I) that can be used in the treatment of CBM complex pathway-associated diseases, including various types of cancers, autoimmune disorders, and inflammatory disorders. The compound can inhibit mammalian cell proliferation, CBM complex pathway activity, and MALT1 protease activity. The patent also covers methods for identifying and treating CBM complex pathway-associated diseases using the compound. Additionally, the patent application includes processes for preparing the compound, pharmaceutical compositions, and methods for administering the compound to treat specific conditions. Overall, the patent application provides a comprehensive framework for the development and application of the compound in the field of medicine.
To know more about GlobalData’s detailed insights on Schrodinger, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
